Gilead appoints Dr. Muzammil M. Mansuri as SVP, R&D

Thursday, April 28, 2011 12:58 PM

Gilead Sciences, has appointed Muzammil M. (“Muz”) Mansuri, PhD, to senior vice president, research and development strategy and corporate development, a role that expands his current responsibilities to include leadership of corporate development and alliance management.

Mansuri joined Gilead in July 2010, following the company’s acquisition of CGI Pharmaceuticals. Prior to joining Gilead, Mansuri served as the chief executive officer or chief operating officer at several biotechnology companies, including CGI, BIKAM Pharmaceuticals, Sequoia Pharmaceuticals, GPC Biotech and Mitotix. He also was a general partner with Flagship Ventures and served on the boards of CGI, AVEO Pharmaceuticals, BG Medicine and Adaptive Therapeutics.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs